- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
452
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
452 companies
Birzeit Pharmaceuticals
Market Cap: US$141.5m
Manufactures and trades in various medicines in the Palestinian Authority.
BPC
US$3.65
7D
1.4%
1Y
-13.7%
Rallybio
Market Cap: US$26.2m
A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.
RLYB
US$0.64
7D
-3.7%
1Y
-60.6%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
Market Cap: HK$7.2b
Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.
1349
HK$2.74
7D
3.8%
1Y
20.2%
Blueberries Medical
Market Cap: CA$4.0m
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.
BBM
CA$0.01
7D
-33.3%
1Y
-60.0%
Simply Better Brands
Market Cap: CA$103.7m
Operates as an omni-channel platform with diversified assets in the plant-based and wellness consumer product categories.
SBBC
CA$1.01
7D
0%
1Y
159.0%
Aadi Bioscience
Market Cap: US$48.8m
A biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes.
AADI
US$2.10
7D
8.8%
1Y
-0.9%
InnoCan Pharma
Market Cap: CA$60.9m
A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.
INNO
CA$0.20
7D
0%
1Y
-32.2%
NervGen Pharma
Market Cap: CA$191.2m
Engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage.
NGEN
CA$2.75
7D
-1.4%
1Y
12.7%
ALT5 Sigma
Market Cap: US$65.3m
Operates a next generation blockchain platform.
ALTS
US$4.52
7D
-4.2%
1Y
60.9%
Nuo Therapeutics
Market Cap: US$63.0m
A regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States.
AURX
US$1.35
7D
-0.3%
1Y
49.6%
Hamlet BioPharma
Market Cap: SEK 728.5m
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
HAMLET B
SEK 4.10
7D
-3.3%
1Y
101.0%
Abliva
Market Cap: SEK 715.7m
Abliva AB (publ) discovers and develops medicines for the treatment of mitochondrial disease in Sweden.
ABLI
SEK 0.44
7D
-1.1%
1Y
196.0%
Telescope Innovations
Market Cap: CA$19.6m
A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.
TELI
CA$0.36
7D
-8.8%
1Y
-3.9%
180 Life Sciences
Market Cap: US$3.4m
A clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases.
ATNF
US$1.07
7D
-5.3%
1Y
-68.3%
Hexima
Market Cap: AU$2.2m
Does not have significant operations.
HXL
AU$0.013
7D
0%
1Y
-18.8%
Autolus Therapeutics
Market Cap: US$497.6m
A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases.
AUTL
US$1.82
7D
-6.2%
1Y
-70.7%
Cytophage Technologies
Market Cap: CA$9.4m
A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.
CYTO
CA$0.17
7D
-8.1%
1Y
-64.6%
CASI Pharmaceuticals
Market Cap: US$34.5m
A biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally.
CASI
US$2.26
7D
0.9%
1Y
-25.4%
Seer
Market Cap: US$116.6m
A life sciences company, engages in developing and commercializing products to decode the biology of the proteome.
SEER
US$1.94
7D
1.6%
1Y
2.6%
Harvard Apparatus Regenerative Technology
Market Cap: US$35.5m
A clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects.
HRGN
US$2.23
7D
-9.1%
1Y
-28.1%
Proteomics International Laboratories
Market Cap: AU$64.2m
Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia.
PIQ
AU$0.49
7D
2.1%
1Y
-48.1%
Zhejiang Yatai Pharmaceutical
Market Cap: CN¥2.5b
Researches, produces, sells, and exports pharmaceutical products in China and internationally.
002370
CN¥3.45
7D
3.6%
1Y
-5.2%
ImmuCell
Market Cap: US$44.5m
An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
ICCC
US$4.97
7D
2.1%
1Y
-0.4%
Malaysian Genomics Resource Centre Berhad
Market Cap: RM 35.7m
An investment holding company, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide.
MGRC
RM 0.26
7D
2.0%
1Y
-40.9%
Inhibitor Therapeutics
Market Cap: US$12.1m
A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.
INTI
US$0.07
7D
0.7%
1Y
0%
Imugene
Market Cap: AU$261.0m
A clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.
IMU
AU$0.035
7D
0%
1Y
-68.2%
Incannex Healthcare
Market Cap: US$13.2m
A clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia.
IXHL
US$0.74
7D
-5.1%
1Y
-79.2%
Intensity Therapeutics
Market Cap: US$35.0m
A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs in the United States.
INTS
US$2.24
7D
0.4%
1Y
-53.8%
Pila Pharma
Market Cap: SEK 95.2m
PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden.
PILA
SEK 3.51
7D
1.7%
1Y
188.9%
Tiziana Life Sciences
Market Cap: US$169.1m
A biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States.
TLSA
US$1.55
7D
13.1%
1Y
216.3%
Renovaro
Market Cap: US$127.8m
A pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands.
RENB
US$0.77
7D
-11.5%
1Y
-74.4%
Vitura Health
Market Cap: AU$48.3m
Engages in the sale and distribution of medicinal cannabis products in Australia.
VIT
AU$0.073
7D
4.3%
1Y
-51.3%
Orthocell
Market Cap: AU$328.7m
A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.
OCC
AU$1.37
7D
9.2%
1Y
251.3%
Viva Biotech Holdings
Market Cap: HK$4.1b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.95
7D
42.3%
1Y
261.1%
AbCellera Biologics
Market Cap: US$750.9m
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development.
ABCL
US$2.54
7D
15.5%
1Y
-44.7%
PharmaTher Holdings
Market Cap: CA$17.7m
A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.
PHRM
CA$0.20
7D
7.9%
1Y
-41.4%